Dyne Therapeutics, Inc. (NASDAQ:DYN) IPO
IPO
Priced at US$19.00 a share on Sep 16, 2020.
- Price
- US$19.00 a share
- Shares offered
- 12,251,578 shares of common stock
- Offering size
- US$232.8 million
- Underwriters' option
- Up to 1,837,736 more shares
- Underwriters
- J.P. Morgan, Jefferies, Piper Sandler, Stifel · In the order on the cover
- Shares delivered
- On or about Sep 21, 2020
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Jul 23, 2020 |
| Filed publicly | Aug 25, 2020 |
| Amended once | Sep 10, 2020 |
| Shares registered with an exchange | Sep 11, 2020 |
| Declared effective by the SEC | Sep 16, 2020 |
| Final prospectus, with the price | Sep 17, 2020 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Sep 17, 2020 |
| EFFECT · Notice that a registration is effective | Sep 16, 2020 |
| S-1MEF · Registration of more shares for the same offering | Sep 16, 2020 |
| CERT · Exchange's certificate of listing | Sep 16, 2020 |
| CORRESP · Letter to the SEC | Sep 14, 2020 |
| CORRESP · Letter to the SEC | Sep 14, 2020 |
| 8-A12B · Registration of shares for listing on an exchange | Sep 11, 2020 |
| UPLOAD · Letter from the SEC | Sep 10, 2020 |
| CORRESP · Letter to the SEC | Sep 10, 2020 |
| S-1/A · Registration statement, amended | Sep 10, 2020 |
| CORRESP · Letter to the SEC | Aug 25, 2020 |
| S-1 · Registration statement | Aug 25, 2020 |
| UPLOAD · Letter from the SEC | Aug 20, 2020 |
| DRS · Draft registration statement | Jul 23, 2020 |
From the cover of the final prospectus (424B4) filed Sep 17, 2020